X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with GSK Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs GSK PHARMA - Comparison Results

GSK PHARMA 
   Change

GSK Pharma is one of the leading MNC pharma companies in the Indian market. It is a 50.7% subsidiary of GlaxoSmithKline Plc, one of the world's largest pharma companies. GSK Pharma's product portfolio boasts of some of the leading brands like Augment... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES GSK PHARMA JUBILANT LIFE SCIENCES/
GSK PHARMA
 
P/E (TTM) x 26.0 65.0 40.0% View Chart
P/BV x 5.3 10.4 51.1% View Chart
Dividend Yield % 0.3 1.2 28.1%  

Financials

 JUBILANT LIFE SCIENCES   GSK PHARMA
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
GSK PHARMA
Mar-17
JUBILANT LIFE SCIENCES/
GSK PHARMA
5-Yr Chart
Click to enlarge
High Rs1873,838 4.9%   
Low Rs652,637 2.5%   
Sales per share (Unadj.) Rs364.3354.2 102.9%  
Earnings per share (Unadj.) Rs6.839.8 17.2%  
Cash flow per share (Unadj.) Rs24.542.9 57.1%  
Dividends per share (Unadj.) Rs3.0030.00 10.0%  
Dividend yield (eoy) %2.40.9 257.0%  
Book value per share (Unadj.) Rs164.9236.9 69.6%  
Shares outstanding (eoy) m159.2884.70 188.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.39.1 3.8%   
Avg P/E ratio x18.481.4 22.6%  
P/CF ratio (eoy) x5.175.5 6.8%  
Price / Book Value ratio x0.813.7 5.6%  
Dividend payout %43.875.4 58.1%   
Avg Mkt Cap Rs m20,061274,216 7.3%   
No. of employees `0006.24.7 131.7%   
Total wages/salary Rs m11,0524,830 228.8%   
Avg. sales/employee Rs Th9,383.06,387.0 146.9%   
Avg. wages/employee Rs Th1,786.91,028.3 173.8%   
Avg. net profit/employee Rs Th176.3717.1 24.6%   
INCOME DATA
Net Sales Rs m58,03430,000 193.4%  
Other income Rs m191728 26.2%   
Total revenues Rs m58,22430,728 189.5%   
Gross profit Rs m5,7864,190 138.1%  
Depreciation Rs m2,812263 1,069.1%   
Interest Rs m3,2370-   
Profit before tax Rs m-724,655 -1.5%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,145457 469.3%   
Tax Rs m6961,744 39.9%   
Profit after tax Rs m1,0903,368 32.4%  
Gross profit margin %10.014.0 71.4%  
Effective tax rate %-965.937.5 -2,578.1%   
Net profit margin %1.911.2 16.7%  
BALANCE SHEET DATA
Current assets Rs m29,28016,742 174.9%   
Current liabilities Rs m38,9127,202 540.3%   
Net working cap to sales %-16.631.8 -52.2%  
Current ratio x0.82.3 32.4%  
Inventory Days Days8452 162.9%  
Debtors Days Days5121 243.9%  
Net fixed assets Rs m55,7128,635 645.2%   
Share capital Rs m155847 18.2%   
"Free" reserves Rs m20,96819,222 109.1%   
Net worth Rs m26,26520,069 130.9%   
Long term debt Rs m17,16910 171,688.0%   
Total assets Rs m88,60630,038 295.0%  
Interest coverage x1.0NM-  
Debt to equity ratio x0.70 131,182.9%  
Sales to assets ratio x0.71.0 65.6%   
Return on assets %4.911.2 43.6%  
Return on equity %4.216.8 24.7%  
Return on capital %11.625.5 45.4%  
Exports to sales %37.80-   
Imports to sales %16.50-   
Exports (fob) Rs m21,933NA-   
Imports (cif) Rs m9,567NA-   
Fx inflow Rs m22,004528 4,167.4%   
Fx outflow Rs m11,7497,193 163.3%   
Net fx Rs m10,255-6,665 -153.9%   
CASH FLOW
From Operations Rs m8,0262,360 340.1%  
From Investments Rs m-1,7443,008 -58.0%  
From Financial Activity Rs m-4,447-5,108 87.1%  
Net Cashflow Rs m1,834260 704.7%  

Share Holding

Indian Promoters % 45.6 0.0 -  
Foreign collaborators % 3.5 50.7 6.9%  
Indian inst/Mut Fund % 8.7 10.2 85.3%  
FIIs % 21.2 23.8 89.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 15.4 137.0%  
Shareholders   23,815 102,036 23.3%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   AUROBINDO PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  J.B.CHEMICALS  MERCK LTD  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Jan 19, 2018 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS